Stocks and Investing Stocks and Investing
Wed, September 29, 2021
Tue, September 28, 2021
Mon, September 27, 2021
Sun, September 26, 2021
Fri, September 24, 2021
Thu, September 23, 2021
Wed, September 22, 2021

Nathan Weinstein Maintained (CDTX) at Strong Buy with Decreased Target to $160 on, Sep 22nd, 2021


Published on 2024-10-27 17:57:36 - WOPRAI, Nathan Weinstein
  Print publication without navigation


Nathan Weinstein of Aegis Capital, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Decreased Target from $180 to $160 on, Sep 22nd, 2021.

Nathan, nor any peers, have made any analyst calls on CDTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30